| Jaclyn Theresa Le, | |
|
22175 E Hinsdale Ave, Aurora, CO 80016-6009 | |
| (720) 404-2860 | |
| Not Available |
| Full Name | Jaclyn Theresa Le |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 22175 E Hinsdale Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073826764 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 0999203 (Colorado) | Primary |
| 163W00000X | Registered Nurse | 194930 (Colorado) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Jaclyn Theresa Le, 7048 S Picadilly St, Aurora, CO 80016-2345 Ph: (720) 404-2860 | Jaclyn Theresa Le, 22175 E Hinsdale Ave, Aurora, CO 80016-6009 Ph: (720) 404-2860 |
News Archive
Competitive Technologies, Inc. today announced the presentation of results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy using CTT's Calmare Pain Therapy Treatment. A three-hour discussion led by principal investigator, Thomas J. Smith, M.D., Endowed Chair of Palliative Care Research and Medical Director of the Thomas Palliative Care Unit Virginia Commonwealth University's Massey Cancer Center, at the American Society of Clinical Oncology Annual Meeting, cited results of the study.
The new variant of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detected in England replicates more than two times faster than the earlier strains. This replication advantage promises to make it the dominant global variant very shortly. This finding comes from a startling preprint that appeared on the medRxiv* server in December 2020.
GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Metformin Hydrochloride Extended-release Tablets USP, 1000 mg.
Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.
› Verified 4 days ago
Mrs. Kristen L Holder, FNP-C, APRN-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Kate Coleman Minahan, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Mrs. Jill M Marks, RN, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Kristi Wharton Swim, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Lauren Reed, C.P.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Ashley Wigington, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14221 E 4th Ave Ste 2-126, Aurora, CO 80011 Phone: 720-507-4779 Fax: 720-367-5067 | |
Brianna Bogdajewicz, Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 791 Chambers Rd, Aurora, CO 80011 Phone: 303-617-2300 |